Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Medicines With The Active Ingredient Glatiramer Acetate (atc 2026-06-19
Germany Conclusion Not Excluding Drug Discount Agreement. According To Section 130a Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Solifenacin/tamsulosin (atc Code According To Who: G04ca53) 2026-06-20
Germany Conclusion Not Excluding Drug Discount Agreement. According To Section 130a Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Dexamethasone (atc Code According To Who: S01ba01) 2026-06-20
Germany Conclusion Not Excluding Drug Discount Agreement. According To Section 130a Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Solifenacin/tamsulosin (atc Code According To Who: G04ca53) 2026-06-20
Germany Conclusion Not Excluding Drug Discount Agreement. According To Section 130a Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Dexamethasone (atc Code According To Who: S01ba01) 2026-06-20
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Methoxypolyethylene Glycol Epoetin Beta, Atc B03xa03 2026-06-20
Germany Openhouse Biological Discount Contracts 202536 Natalizumab (form For Subcutaneous Injection) 2026-06-20
Paraguay Acquisition Of Tools, Devices, And Instruments In General 2026-06-20
Netherlands The Tablets 2026-06-20
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph. 8 Sgb V On Medicines With The Active Ingredient Alfacalcidol (atccode 2026-06-20
Whats app